[277 Pages Report] The global ultrasound market is projected to reach USD 9.0 billion by 2026 from USD 6.7 billion in 2021, at a CAGR of 6.3% during the forecast period. Ongoing technological advancements in the field of diagnostic & therapeutic ultrasound imaging, availability of medical reimbursements for diagnostic ultrasound procedures in mature markets, and the growing applications of emerging ultrasound techniques (such as Doppler ultrasound in vascular imaging and 3D/4D ultrasound in oncology) are driving the growth of ultrasound market.
To know about the assumptions considered for the study, Request for Free Sample Report
The impact of the COVID-19 pandemic and the lockdowns it triggered is clearly visible on various markets, including the ultrasound market. Over the last year, the overall growth of various sectors has been heavily impacted, specifically in countries with a high incidence rate of COVID-19, such as India, Brazil, China, the US, and several European countries (including Russia, Italy, the UK, and Spain). While industries such as oil and petroleum, aeronautics, and mining are experiencing a steep fall in revenues, the healthcare, biotechnology, and pharmaceutical industries are focusing on optimizing their operations to serve a maximum number of patients and healthcare professionals.
The ultrasound market has been negatively impacted by the pandemic, and this trend is expected to continue till December 2021. Unfavorable changes in regulations and guidelines are hampering the growth of this market. The closing down of manufacturing facilities due to lockdowns, disruptions in supply chains, and recruitment challenges for clinical trials have further impacted the growth of the overall ultrasound market.
The high and increasing incidence of target diseases and conditions will boost the adoption of effective diagnostic and therapeutic procedures. The burden of chronic and lifestyle diseases has increased in recent years. The burden of cancer, for example, was expected to increase from 14.1 million new cases in 2012 to 19.3 million new cases in 2020 (Source: GLOBOCAN, 2020).
As ultrasound technologies are cost-effective, safer, and offer earlier diagnosis & treatment of target diseases, their demand in disease management is expected to increase during the forecast period. Important statistics related to other major target diseases have been mentioned below:
In August 2012, the US government planned to reduce Medicare spending by USD 716 billion over the next ten years (until 2022). Many industry participants expect that this health reform will negatively affect the cash flow for medical device companies operating in the US (including those involved in the manufacturing and marketing of ultrasound systems). This may limit the adoption of such devices in the US, as a number of healthcare facilities depend on government funds for purchasing high-end, highly expensive instruments.
Minimally invasive therapies and image-guided procedures are increasingly being adopted by healthcare professionals and patients across the world. The ultrasound industry has witnessed a significant shift from being a conventional diagnostic modality for OB/GYN imaging to a therapeutic technique for renal stones, cancers, and other clinical conditions. It can be expected that such efforts will open up new avenues for revenue growth for manufacturers in this market.
Due to the high prices of novel ultrasound technologies (such as focused ultrasound) and budgetary constraints faced by small-sized healthcare providers, the preference for refurbished ultrasound equipment has grown. For instance, a typical 3D/4D ultrasound system costs USD 20,00075,000 in North America, while a refurbished 3D/4D ultrasound system costs USD 5,00040,000. The growing preference for refurbished systems is, therefore, expected to pose a significant challenge to market growth.
To know about the assumptions considered for the study, download the pdf brochure
Based on technology, the ultrasound market is segmented into diagnostic ultrasound (2D, 3D & 4D, and Doppler ultrasound) and therapeutic ultrasound (focused ultrasound and shockwave lithotripsy). The diagnostic ultrasound segment is expected to account for the larger share of the ultrasound market in 2020. The large share of this segment can be attributed to the significant usage of 2D ultrasound in womens health, availability of medical reimbursements for diagnostic ultrasound procedures in mature markets, ongoing technological advancements in the field of diagnostic ultrasound imaging, and the growing applications of emerging ultrasound techniques.
On the basis of system portability, the ultrasound market is segmented into trolley/cart-based ultrasound systems, compact/handheld ultrasound systems, and point-of-care ultrasound systems. The trolley/cart-based ultrasound systems segment is expected to account for the largest share of the ultrasound market in 2020. The large share of this segment is attributed to the growing adoption of these systems across major markets due to their increased usage in acute care settings and emergency care in hospitals and healthcare institutions.
On the basis of application, the ultrasound market is segmented into radiology/general imaging, obstetrics/gynecology, cardiologic applications, vascular applications, urological applications, orthopedic & musculoskeletal applications, pain management, and other applications. The radiology/general imaging applications segment is expected to command the largest share of the ultrasound market in 2020. Factors such as the rising incidence of various cancers across major countries, technological advancements in the field of ultrasound-based diagnosis and treatment, growing market availability and physician preference for HIFU in cancer treatment, increasing usage of ultrasound in cancer diagnosis and tissue biopsy, and the rising adoption of focused ultrasound in disease therapies are driving the growth of the radiology/general imaging segment.
Based on end user, the ultrasound market is segmented into hospitals, surgical centers, and diagnostic centers; maternity centers; ambulatory care centers; research and academia; and other end users. The hospitals, surgical centers, and diagnostic centers segment is expected to account for the largest share of the ultrasound market in 2020. The large share of this segment can be attributed to factors such as a significant number of ultrasound-based medical procedures performed in hospitals, coupled with the growing number of hospitals across major markets, and rising adoption of minimally invasive diagnostic & surgical procedures in these facilities.
The report covers the ultrasound market across five major geographies, namely, Europe, North America, Asia Pacific, Latin America and MEA. Europe is expected to command the largest share of the ultrasound market in 2020. Factors such as a large number of ongoing clinical research projects in the field of ultrasound, expansions in the clinical applications of focused ultrasound and the early commercialization of these devices in the region, and the significant healthcare expenditure across mature European countries (such as Germany, France, the UK, Italy, and Spain) are driving the growth of the ultrasound market in Europe.
The major players in the ultrasound market are GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems (Japan), Siemens AG (Germany), Hitachi (Japan), Samsung Electronics (South Korea), and FUJIFILM Holdings Corporation (Japan). The other prominent players operating in this market include Esaote S.p.A. (Italy), Mindray Medical International Ltd. (China), Analogic Corporation (US), Carestream (US), Hologic (US), Mobisnate (US), and Chison Medical Imaging (China).
GE Healthcare (a key business division of General Electric Company) is among the top players engaged in the development and manufacturing of diagnostic ultrasound systems. The company focuses on maintaining its leadership position in the ultrasound market through pipeline development and product commercialization. From 2018 to 2021, the ultrasound market witnessed the commercialization of key ultrasound products by GE Healthcare, including the Versana Premier ultrasound system, Invenia Automated Breast Ultrasound (ABUS) 2.0 system, and Versana Essential ultrasound.
|
Report Metric |
Details |
|
Market size available for years |
20192026 |
|
Base year considered |
2020 |
|
Forecast period |
20212026 |
|
Forecast units |
Value (USD Billion) |
|
Segments covered |
Technology, Device Display, System Portability, Application, Component, End User, and Region |
|
Geographies covered |
Europe, North America, the Asia Pacific, Latin America, and Middle East and Africa |
|
Companies covered |
GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Hitachi, Ltd. (Japan), Siemens Healthineers AG (Germany), Hologic, Inc. (US), FUJIFILM Holdings Corporation (Japan), Samsung Electronics Co., Ltd. (Korea), Mindray Medical International Limited (China), Analogic Corporation (US), Esaote S.p.A (Italy), Carestream Health (US), CURA Healthcare (India), Chison Medical Technologies Co., Ltd. (China), Mobisante, Inc. (US), Neusoft Corporation (China), Clarius Mobile Health (Canada), Medgyn Products, Inc. (US), and United Imaging Healthcare Co., Ltd. (China), among others |
This report has segmented the global ultrasound market based on technology, device display, system portability, application, component, end user, and region.
What is the expected addressable market value of major ultrasound devices over a 5-year period?
The global ultrasound market is projected to reach USD 9.0 billion by 2026 from USD 6.7 billion in 2021, at a CAGR of 6.3% during the forecast period.
Which technology segment is expected to garner the highest traction within the ultrasound market?
Based on technology, the ultrasound market is segmented into diagnostic ultrasound (further segmented into 2D, 3D & 4D, and Doppler ultrasound) and therapeutic ultrasound (further segmented into HIFU and ESWL). The diagnostic ultrasound segment accounted for a larger share of the ultrasound market in 2019. This can be attributed to technological advancements and new product launches in the segment.
What are the strategies adopted by the top market players to penetrate across emerging regions?
The key growth strategies adopted by the top players in this market include product launches and approvals; research & distribution agreements, and partnerships; expansions; and acquisitions.
What are the major factors expected to limit the growth of the ultrasound market?
Lack of trained professionals, stringent regulatory approval process, and rising adoption of refurbished equipment across emerging economies are some of the major factors liming the growth of the market.
What is the adoption pattern for novel ultrasound technologies across major healthcare markets?
The Asia Pacific (APAC) market is expected to record the highest CAGR during the forecast period. Growth of the regional market can primarily be attributed to factors such as rapidly increasing patient population, increasing healthcare expenditure, and improving healthcare infrastructure in the region. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 32)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 MARKET STAKEHOLDERS
1.6 LIMITATIONS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 37)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 VENDOR REVENUE-BASED MARKET SIZE ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.2.2 END USER-BASED MARKET SIZE ESTIMATION
FIGURE 5 ULTRASOUND MARKET: END USER-BASED ESTIMATION
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 COVID-19 HEALTH ASSESSMENT
2.4 COVID-19 ECONOMIC ASSESSMENT
2.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 6 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 7 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
2.6 DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.7 RESEARCH ASSUMPTIONS
2.8 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. - 48)
FIGURE 9 ULTRASOUND MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
FIGURE 10 ULTRASOUND MARKET SHARE, BY DISPLAY TYPE, 2021 VS. 2026
FIGURE 11 ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2021 VS. 2026 (USD MILLION)
FIGURE 12 ULTRASOUND MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 13 ULTRASOUND MARKET SHARE, BY END USER, 2021 VS. 2026
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF THE ULTRASOUND MARKET
4 PREMIUM INSIGHTS (Page No. - 53)
4.1 ULTRASOUND MARKET OVERVIEW
FIGURE 15 TECHNOLOGICAL ADVANCEMENTS AND INCREASING PREVALENCE OF TARGET DISEASES TO DRIVE THE GROWTH OF THE ULTRASOUND MARKET
4.2 EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE AND COUNTRY
FIGURE 16 GERMANY IS THE LARGEST MARKET FOR DIAGNOSTIC ULTRASOUND IN EUROPE
4.3 ULTRASOUND MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 17 VASCULAR APPLICATIONS SEGMENT TO REGISTER SUBSTANTIAL GROWTH IN THE GLOBAL ULTRASOUND MARKET
4.4 GEOGRAPHIC SNAPSHOT OF THE ULTRASOUND MARKET
FIGURE 18 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 56)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 ULTRASOUND MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence of target diseases
5.2.1.2 Rising patient preference for minimally invasive procedures
5.2.1.3 Technological advancements
TABLE 1 RECENT PRODUCT LAUNCHES/APPROVALS IN THE ULTRASOUND MARKET
5.2.1.4 Growing public and private investments, funding, and grants
5.2.1.5 Increasing number of diagnostic centers & hospitals
5.2.2 RESTRAINTS
5.2.2.1 Unfavorable healthcare reforms in the US
5.2.3 OPPORTUNITIES
5.2.3.1 Expanding applications of therapeutic ultrasound
5.2.3.2 Emerging markets
5.2.3.3 Development of POC ultrasound devices
5.2.4 CHALLENGES
5.2.4.1 Growing end-user preference for refurbished equipment
5.2.4.2 Dearth of skilled and well-trained sonographers
5.3 INDUSTRY TRENDS
5.3.1 DEVELOPMENT OF APPLICATION-SPECIFIC ULTRASOUND DEVICES
5.3.2 GROWING USE OF ULTRASOUND IN ELASTOGRAPHY
5.3.3 INCREASING USE OF MR-GUIDED ULTRASOUND MODALITIES IN NEUROLOGY APPLICATIONS
5.4 PRICING TREND ANALYSIS (20172020)
5.4.1 NORTH AMERICA
5.4.2 EUROPE
5.4.3 ASIA PACIFIC
5.4.4 REST OF THE WORLD
5.5 VALUE CHAIN ANALYSIS
FIGURE 20 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING THE MANUFACTURING PHASE
5.6 REGULATORY ANALYSIS
5.6.1 NORTH AMERICA
5.6.1.1 US
TABLE 2 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 3 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.6.1.2 Canada
TABLE 4 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 21 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.6.2 EUROPE
FIGURE 22 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
5.6.3 ASIA PACIFIC
5.6.3.1 Japan
TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.6.3.2 China
TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.6.3.3 India
5.7 PORTERS FIVE FORCES ANALYSIS
TABLE 7 ULTRASOUND MARKET: PORTERS FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF SUPPLIERS
5.7.4 BARGAINING POWER OF BUYERS
5.7.5 DEGREE OF COMPETITION
5.8 COVID-19 IMPACT ON THE ULTRASOUND MARKET
5.9 ECOSYSTEM COVERAGE: ULTRASOUND MARKET
5.10 PATENT ANALYSIS
FIGURE 23 TOP 10 PATENT APPLICANTS FOR ULTRASOUND (DECEMBER 2021)
FIGURE 24 PATENT APPLICATIONS FOR ULTRASOUND (JANUARY 2011 TO DECEMBER 2021)
FIGURE 25 TOP 10 PATENT APPLICANTS FOR THERAPEUTIC ULTRASOUND (JANUARY 2011 TO AUGUST 2021)
FIGURE 26 PATENT APPLICATIONS FOR THERAPEUTIC ULTRASOUND (JANUARY 2011 TO DECEMBER 2021)
FIGURE 27 TOP 10 PATENT APPLICANTS FOR POINT-OF-CARE ULTRASOUND (JANUARY 2011 TO AUGUST 2021)
FIGURE 28 PATENT APPLICATIONS FOR POINT-OF-CARE ULTRASOUND (JANUARY 2011 TO DECEMBER 2021)
5.11 TRADE ANALYSIS FOR ULTRASOUND SYSTEMS
TABLE 8 IMPORT DATA FOR ULTRASOUND SYSTEMS, BY COUNTRY, 20162020 (USD MILLION)
TABLE 9 EXPORT DATA FOR ULTRASOUND SYSTEMS, BY COUNTRY, 20162020 (USD MILLION)
6 ULTRASOUND MARKET, BY TECHNOLOGY (Page No. - 83)
6.1 INTRODUCTION
TABLE 10 ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
6.2 DIAGNOSTIC ULTRASOUND
TABLE 11 DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 12 DIAGNOSTIC ULTRASOUND MARKET, BY REGION, 20192026 (USD MILLION)
6.2.1 DIAGNOSTIC ULTRASOUND MARKET, BY DISPLAY TYPE, 20192026 (USD MILLION)
TABLE 13 DIAGNOSTIC ULTRASOUND MARKET, BY DISPLAY TYPE, 20192026 (USD MILLION)
6.2.2 DIAGNOSTIC ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 20192026 (USD MILLION)
TABLE 14 DIAGNOSTIC ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 20192026 (USD MILLION)
6.2.3 DIAGNOSTIC ULTRASOUND MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 15 DIAGNOSTIC ULTRASOUND MARKET, BY APPLICATION, 20192026 (USD MILLION)
6.2.4 DIAGNOSTIC ULTRASOUND MARKET, BY END USER, 20192026 (USD MILLION)
TABLE 16 DIAGNOSTIC ULTRASOUND MARKET, BY END USER, 20192026 (USD MILLION)
6.2.5 2D ULTRASOUND
6.2.5.1 Strong market demand from less-developed and emerging countries to sustain the growth of this segment
TABLE 17 2D ULTRASOUND MARKET, BY REGION, 20192026 (USD MILLION)
6.2.6 2D ULTRASOUND MARKET, BY DISPLAY TYPE, 20192026 (USD MILLION)
TABLE 18 2D ULTRASOUND MARKET, BY DISPLAY TYPE, 20192026 (USD MILLION)
6.2.7 2D ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 20192026 (USD MILLION)
TABLE 19 2D ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 20192026 (USD MILLION)
6.2.8 2D ULTRASOUND MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 20 2D ULTRASOUND MARKET, BY APPLICATION, 20192026 (USD MILLION)
6.2.9 2D ULTRASOUND MARKET, BY END USER, 20192026 (USD MILLION)
TABLE 21 2D ULTRASOUND MARKET, BY END USER, 20192026 (USD MILLION)
6.2.10 3D AND 4D ULTRASOUND
6.2.10.1 Greater diagnostic accuracy and improved imaging capabilities to boost the global market demand for 3D/4D ultrasound
TABLE 22 3D AND 4D ULTRASOUND MARKET, BY REGION, 20192026 (USD MILLION)
6.2.11 3D AND 4D ULTRASOUND MARKET, BY DISPLAY TYPE, 20192026 (USD MILLION)
TABLE 23 3D AND 4D ULTRASOUND MARKET, BY DISPLAY TYPE, 20192026 (USD MILLION)
6.2.12 3D AND 4D ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 20192026 (USD MILLION)
TABLE 24 3D AND 4D ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 20192026 (USD MILLION)
6.2.13 3D AND 4D ULTRASOUND MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 25 3D AND 4D ULTRASOUND MARKET, BY APPLICATION, 20192026 (USD MILLION)
6.2.14 3D AND 4D ULTRASOUND MARKET, BY END USER, 20192026 (USD MILLION)
TABLE 26 3D AND 4D ULTRASOUND MARKET, BY END USER, 20192026 (USD MILLION)
6.2.15 DOPPLER ULTRASOUND
6.2.15.1 Growing application in pain management, cardiovascular imaging, and emergency care to drive market growth
TABLE 27 DOPPLER ULTRASOUND MARKET, BY REGION, 20192026 (USD MILLION)
6.2.16 DOPPLER ULTRASOUND MARKET, BY DISPLAY TYPE, 20192026 (USD MILLION)
TABLE 28 DOPPLER ULTRASOUND MARKET, BY DISPLAY TYPE, 20192026 (USD MILLION)
6.2.17 DOPPLER ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 20192026 (USD MILLION)
TABLE 29 DOPPLER ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 20192026 (USD MILLION)
6.2.18 DOPPLER ULTRASOUND MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 30 DOPPLER ULTRASOUND MARKET, BY APPLICATION, 20192026 (USD MILLION)
6.2.19 DOPPLER ULTRASOUND MARKET, BY END USER, 20192026 (USD MILLION)
TABLE 31 DOPPLER ULTRASOUND MARKET, BY END USER, 20192026 (USD MILLION)
6.3 THERAPEUTIC ULTRASOUND
TABLE 32 THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 33 THERAPEUTIC ULTRASOUND MARKET, BY REGION, 20192026 (USD MILLION)
6.3.1 THERAPEUTIC ULTRASOUND MARKET, BY DISPLAY TYPE, 20192026 (USD MILLION)
TABLE 34 THERAPEUTIC ULTRASOUND MARKET, BY DISPLAY TYPE, 20192026 (USD MILLION)
6.3.2 THERAPEUTIC ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 20192026 (USD MILLION)
TABLE 35 THERAPEUTIC ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 20192026 (USD MILLION)
6.3.3 THERAPEUTIC ULTRASOUND MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 36 THERAPEUTIC ULTRASOUND MARKET, BY APPLICATION, 20192026 (USD MILLION)
6.3.4 THERAPEUTIC ULTRASOUND MARKET, BY END USER, 20192026 (USD MILLION)
TABLE 37 THERAPEUTIC ULTRASOUND MARKET, BY END USER, 20192026 (USD MILLION)
6.3.5 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY
6.3.5.1 Growing emphasis on the minimally invasive treatment of kidney and gall bladder stones to drive the demand for ESWL
TABLE 38 ESWL ULTRASOUND MARKET, BY REGION, 20192026 (USD MILLION)
6.3.6 ESWL ULTRASOUND MARKET, BY DISPLAY TYPE, 20192026 (USD MILLION)
TABLE 39 ESWL ULTRASOUND MARKET, BY DISPLAY TYPE, 20192026 (USD MILLION)
6.3.7 ESWL ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 20192026 (USD MILLION)
TABLE 40 ESWL ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 20192026 (USD MILLION)
6.3.8 ESWL ULTRASOUND MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 41 ESWL ULTRASOUND MARKET, BY APPLICATION, 20192026 (USD MILLION)
6.3.9 ESWL ULTRASOUND MARKET, BY END USER, 20192026 (USD MILLION)
TABLE 42 ESWL ULTRASOUND MARKET, BY END USER, 20192026 (USD MILLION)
6.3.10 HIGH-INTENSITY FOCUSED ULTRASOUND
6.3.10.1 Promising results associated with HIFU for the treatment of various cancers to drive market growth
TABLE 43 HIFU ULTRASOUND MARKET, BY REGION, 20192026 (USD MILLION)
6.3.11 HIFU ULTRASOUND MARKET, BY DISPLAY TYPE, 20192026 (USD MILLION)
TABLE 44 HIFU ULTRASOUND MARKET, BY DISPLAY TYPE, 20192026 (USD MILLION)
6.3.12 HIFU ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 20192026 (USD MILLION)
TABLE 45 HIFU ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 20192026 (USD MILLION)
6.3.13 HIFU ULTRASOUND MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 46 HIFU ULTRASOUND MARKET, BY APPLICATION, 20192026 (USD MILLION)
6.3.14 HIFU ULTRASOUND MARKET, BY END USER, 20192026 (USD MILLION)
TABLE 47 HIFU ULTRASOUND MARKET, BY END USER, 20192026 (USD MILLION)
7 ULTRASOUND MARKET, BY SYSTEM PORTABILITY (Page No. - 106)
7.1 INTRODUCTION
TABLE 48 ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 20192026 (USD MILLION)
7.2 TROLLEY/CART-BASED DEVICES
7.2.1 INCREASED USE OF TROLLEY-BASED SYSTEMS FOR ACUTE CARE & EMERGENCY CARE TO DRIVE MARKET GROWTH
TABLE 49 ULTRASOUND MARKET FOR TROLLEY/CART-BASED DEVICES, BY REGION, 20192026 (USD MILLION)
7.3 COMPACT/TABLE-TOP DEVICES
7.3.1 DEVICE AFFORDABILITY AS WELL AS PROCEDURAL & TECHNICAL BENEFITS TO DRIVE THE DEMAND FOR TABLE-TOP DEVICES
TABLE 50 ULTRASOUND MARKET FOR COMPACT/TABLE-TOP DEVICES, BY REGION, 20192026 (USD MILLION)
7.4 POC/PORTABLE DEVICES
7.4.1 IMPROVED OPERATIONAL AND CLINICAL EFFICACY TO BOOST THE DEMAND FOR POC ULTRASOUND DEVICES
TABLE 51 ULTRASOUND MARKET FOR POC/PORTABLE DEVICES, BY REGION, 20192026 (USD MILLION)
8 ULTRASOUND MARKET, BY DISPLAY TYPE (Page No. - 111)
8.1 INTRODUCTION
TABLE 52 ULTRASOUND MARKET, BY DISPLAY TYPE, 20192026 (USD MILLION)
8.2 COLOR ULTRASOUND DEVICES
8.2.1 GREATER MARKET AVAILABILITY OF ADVANCED COLOR ULTRASOUND DEVICES TO DRIVE THE MARKET
TABLE 53 COLOR ULTRASOUND DEVICES MARKET, BY REGION, 20192026 (USD MILLION)
8.3 BLACK & WHITE ULTRASOUND DEVICES
8.3.1 ASIA PACIFIC REGION TO REGISTER SUSTAINED DEMAND FOR B/W ULTRASOUND DEVICES
TABLE 54 BLACK & WHITE ULTRASOUND DEVICES MARKET, BY REGION, 20192026 (USD MILLION)
9 ULTRASOUND MARKET, BY APPLICATION (Page No. - 115)
9.1 INTRODUCTION
TABLE 55 ULTRASOUND MARKET, BY APPLICATION, 20192026 (USD MILLION)
9.2 RADIOLOGY/GENERAL IMAGING APPLICATIONS
9.2.1 GROWING NUMBER OF IMAGE-GUIDED SURGERIES/RADIOLOGY PROCEDURES TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT
TABLE 56 ULTRASOUND MARKET FOR RADIOLOGY/GENERAL IMAGING APPLICATIONS, BY REGION, 20192026 (USD MILLION)
9.3 CARDIOLOGY APPLICATIONS
9.3.1 RISING PREVALENCE OF CARDIAC DISORDERS TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT
TABLE 57 ULTRASOUND MARKET FOR CARDIOLOGY APPLICATIONS, BY REGION, 20192026 (USD MILLION)
9.4 OBSTETRICS/GYNECOLOGY APPLICATIONS
9.4.1 ULTRASOUND IS WIDELY USED IN THE FIELD OF OBSTETRICS AND GYNECOLOGY
TABLE 58 ULTRASOUND MARKET FOR OBSTETRICS/GYNECOLOGY APPLICATIONS, BY REGION, 20192026 (USD MILLION)
9.5 VASCULAR APPLICATIONS
9.5.1 VASCULAR APPLICATIONS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
TABLE 59 ULTRASOUND MARKET FOR VASCULAR APPLICATIONS, BY REGION, 20192026 (USD MILLION)
9.6 UROLOGICAL APPLICATIONS
9.6.1 ULTRASOUND IS WIDELY USED IN THE DIAGNOSIS AND TREATMENT OF VARIOUS UROLOGICAL DISORDERS
TABLE 60 ULTRASOUND MARKET FOR UROLOGICAL APPLICATIONS, BY REGION, 20192026 (USD MILLION)
9.7 ORTHOPEDIC AND MUSCULOSKELETAL APPLICATIONS
9.7.1 RISING PATIENT PREFERENCE FOR EFFECTIVE & EARLY DISEASE DIAGNOSIS TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT
TABLE 61 ULTRASOUND MARKET FOR ORTHOPEDIC AND MUSCULOSKELETAL APPLICATIONS, BY REGION, 20192026 (USD MILLION)
9.8 PAIN MANAGEMENT APPLICATIONS
9.8.1 ULTRASOUND DEVICES ARE INCREASINGLY BEING UTILIZED FOR TRAUMA & EMERGENCY CARE APPLICATIONS
TABLE 62 ULTRASOUND MARKET FOR PAIN MANAGEMENT APPLICATIONS, BY REGION, 20192026 (USD MILLION)
9.9 OTHER APPLICATIONS
TABLE 63 ULTRASOUND MARKET FOR OTHER APPLICATIONS, BY REGION, 20192026 (USD MILLION)
10 ULTRASOUND MARKET, BY COMPONENT (Page No. - 124)
10.1 INTRODUCTION
TABLE 64 ULTRASOUND MARKET, BY COMPONENT, 20192026 (USD MILLION)
10.2 TRANSDUCERS/PROBES
TABLE 65 TRANSDUCERS/PROBES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 66 TRANSDUCERS/PROBES MARKET, BY REGION, 20192026 (USD MILLION)
10.2.1 CURVILINEAR/CONVEX ARRAY PROBES
10.2.1.1 Growing adoption of POC ultrasound to drive the growth of this market segment
TABLE 67 CURVILINEAR/CONVEX ARRAY PROBES MARKET, BY REGION, 20192026 (USD MILLION)
10.2.2 LINER ARRAY PROBES
10.2.2.1 Increasing target patient population to drive the growth of this market segment
TABLE 68 LINEAR ARRAY PROBES MARKET, BY REGION, 20192026 (USD MILLION)
10.2.3 PHASED ARRAY PROBES
10.2.3.1 Technological advancements to drive the growth of this market segment
TABLE 69 PHASED ARRAY PROBES MARKET, BY REGION, 20192026 (USD MILLION)
10.2.4 OTHER PROBES
TABLE 70 OTHER PROBES MARKET, BY REGION, 20192026 (USD MILLION)
10.3 WORKSTATIONS
10.3.1 INCREASING NUMBER OF DIAGNOSTIC PROCEDURES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
TABLE 71 WORKSTATIONS MARKET, BY REGION, 20192026 (USD MILLION)
10.4 OTHER COMPONENTS
TABLE 72 OTHER COMPONENTS MARKET, BY REGION, 20192026 (USD MILLION)
11 ULTRASOUND MARKET, BY END USER (Page No. - 131)
11.1 INTRODUCTION
TABLE 73 ULTRASOUND MARKET, BY END USER, 20192026 (USD MILLION)
11.2 HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS
11.2.1 SIGNIFICANT NUMBER OF ULTRASOUND-BASED MEDICAL PROCEDURES ARE PERFORMED IN THESE FACILITIES
TABLE 74 ULTRASOUND MARKET FOR HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS, BY REGION, 20192026 (USD MILLION)
11.3 MATERNITY CENTERS
11.3.1 INCREASED ADOPTION OF ADVANCED 3D, 4D, AND DOPPLER ULTRASOUND FOR OB/GYN APPLICATIONS TO DRIVE MARKET GROWTH
TABLE 75 ULTRASOUND MARKET FOR MATERNITY CENTERS, BY REGION, 20192026 (USD MILLION)
11.4 AMBULATORY CARE CENTERS
11.4.1 GROWING NUMBER OF MINIMALLY INVASIVE PROCEDURES PERFORMED AT AMBULATORY CARE CENTERS TO DRIVE MARKET GROWTH
TABLE 76 ULTRASOUND MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 20192026 (USD MILLION)
11.5 RESEARCH AND ACADEMIA
11.5.1 GROWING RESEARCH GRANTS AND FUNDING TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
TABLE 77 ULTRASOUND MARKET FOR RESEARCH AND ACADEMIA, BY REGION, 20192026 (USD MILLION)
11.6 OTHER END USERS
FIGURE 29 NUMBER OF SPORTS INJURIES (2020)
TABLE 78 ULTRASOUND MARKET FOR OTHER END USERS, BY REGION, 20192026 (USD MILLION)
12 ULTRASOUND MARKET, BY REGION (Page No. - 139)
12.1 INTRODUCTION
TABLE 79 ULTRASOUND MARKET, BY REGION, 20192026 (USD MILLION)
12.2 EUROPE
FIGURE 30 EUROPE: ULTRASOUND MARKET SNAPSHOT
TABLE 80 EUROPE: ULTRASOUND MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 81 EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 82 EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 83 EUROPE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 84 EUROPE: ULTRASOUND MARKET, BY DISPLAY TYPE, 20192026 (USD MILLION)
TABLE 85 EUROPE: ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 20192026 (USD MILLION)
TABLE 86 EUROPE: ULTRASOUND MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 87 EUROPE: ULTRASOUND MARKET, BY COMPONENT, 20192026 (USD MILLION)
TABLE 88 EUROPE: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 20192026 (USD MILLION)
TABLE 89 EUROPE: ULTRASOUND MARKET, BY END USER, 20192026 (USD MILLION)
12.2.1 GERMANY
12.2.1.1 Wide acceptance of advanced technologies and favorable reimbursement scenario to drive market growth
TABLE 90 GERMANY: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 91 GERMANY: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 92 GERMANY: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
12.2.2 UK
12.2.2.1 Rising geriatric population to drive market growth in the UK
TABLE 93 UK: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 94 UK: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 95 UK: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
12.2.3 FRANCE
12.2.3.1 Modernization of healthcare infrastructure fueling the demand for ultrasound systems
TABLE 96 FRANCE: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 97 FRANCE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 98 FRANCE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
12.2.4 ITALY
12.2.4.1 Improved reimbursement scenario and increasing R&D to support overall market growth
TABLE 99 ITALY: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 100 ITALY: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 101 ITALY: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
12.2.5 SPAIN
12.2.5.1 Low entry barriers to create opportunities for global players to expand their presence in the country
TABLE 102 SPAIN: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 103 SPAIN: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 104 SPAIN: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
12.2.6 REST OF EUROPE
TABLE 105 REST OF EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 106 REST OF EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 107 REST OF EUROPE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
12.3 NORTH AMERICA
TABLE 108 NORTH AMERICA: ULTRASOUND MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 109 NORTH AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 110 NORTH AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 111 NORTH AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 112 NORTH AMERICA: ULTRASOUND MARKET, BY DISPLAY TYPE, 20192026 (USD MILLION)
TABLE 113 NORTH AMERICA: ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 20192026 (USD MILLION)
TABLE 114 NORTH AMERICA: ULTRASOUND MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 115 NORTH AMERICA: ULTRASOUND MARKET, BY COMPONENT, 20192026 (USD MILLION)
TABLE 116 NORTH AMERICA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 20192026 (USD MILLION)
TABLE 117 NORTH AMERICA: ULTRASOUND MARKET, BY END USER, 20192026 (USD MILLION)
12.3.1 US
12.3.1.1 The US dominated the North American ultrasound market
TABLE 118 POCUS ULTRASOUND CPT CODES (2021)
TABLE 119 CPT CODES FOR ULTRASOUND-GUIDED PROCEDURES (2021)
TABLE 120 US: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 121 US: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 122 US: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
12.3.2 CANADA
12.3.2.1 Growing awareness about early disease diagnosis to drive market growth in Canada
TABLE 123 CANADA: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 124 CANADA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 125 CANADA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
12.4 ASIA PACIFIC
FIGURE 31 ASIA PACIFIC: ULTRASOUND MARKET SNAPSHOT
TABLE 126 ASIA PACIFIC: ULTRASOUND MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 127 ASIA PACIFIC: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 128 ASIA PACIFIC: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 129 ASIA PACIFIC: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 130 ASIA PACIFIC: ULTRASOUND MARKET, BY DISPLAY TYPE, 20192026 (USD MILLION)
TABLE 131 ASIA PACIFIC: ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 20192026 (USD MILLION)
TABLE 132 ASIA PACIFIC: ULTRASOUND MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 133 ASIA PACIFIC: ULTRASOUND MARKET, BY COMPONENT, 20192026 (USD MILLION)
TABLE 134 ASIA PACIFIC: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 20192026 (USD MILLION)
TABLE 135 ASIA PACIFIC: ULTRASOUND MARKET, BY END USER, 20192026 (USD MILLION)
12.4.1 CHINA
12.4.1.1 Increasing patient pool and localized manufacturing to drive the market growth
TABLE 136 CHINA: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 137 CHINA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 138 CHINA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
12.4.2 JAPAN
12.4.2.1 Rising geriatric population to boost market growth in Japan
TABLE 139 JAPAN: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 140 JAPAN: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 141 JAPAN: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
12.4.3 INDIA
12.4.3.1 Significant burden of target diseases and availability of affordable devices to drive market growth
TABLE 142 INDIA: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 143 INDIA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 144 INDIA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
12.4.4 SOUTH KOREA
12.4.4.1 Supportive government initiatives in the country to positively impact market growth
TABLE 145 SOUTH KOREA: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 146 SOUTH KOREA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 147 SOUTH KOREA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
12.4.5 AUSTRALIA
12.4.5.1 Growing research investments and awareness campaigns to drive market growth in Australia
TABLE 148 AUSTRALIA: ULTRASOUND REIMBURSEMENT SCENARIO
TABLE 149 AUSTRALIA: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 150 AUSTRALIA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 151 AUSTRALIA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
12.4.6 REST OF ASIA PACIFIC
TABLE 152 ROAPAC: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 153 ROAPAC: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 154 ROAPAC: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
12.5 LATIN AMERICA
TABLE 155 LATIN AMERICA: ULTRASOUND MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 156 LATIN AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 157 LATIN AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 158 LATIN AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 159 LATIN AMERICA: ULTRASOUND MARKET, BY DISPLAY TYPE, 20192026 (USD MILLION)
TABLE 160 LATIN AMERICA: ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 20192026 (USD MILLION)
TABLE 161 LATIN AMERICA: ULTRASOUND MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 162 LATIN AMERICA: ULTRASOUND MARKET, BY COMPONENT, 20192026 (USD MILLION)
TABLE 163 LATIN AMERICA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 20192026 (USD MILLION)
TABLE 164 LATIN AMERICA: ULTRASOUND MARKET, BY END USER, 20192026 (USD MILLION)
12.5.1 BRAZIL
12.5.1.1 Universal healthcare system to play a pivotal role in driving the use of ultrasound for disease diagnosis
TABLE 165 BRAZIL: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 166 BRAZIL: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 167 BRAZIL: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
12.5.2 MEXICO
12.5.2.1 Modernization of healthcare infrastructure to support market growth in Mexico
TABLE 168 MEXICO: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 169 MEXICO: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 170 MEXICO: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
12.5.3 REST OF LATIN AMERICA
TABLE 171 ROLA: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 172 ROLA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 173 ROLA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
12.6 MIDDLE EAST & AFRICA
12.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA REGION
TABLE 174 MEA: ULTRASOUND MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 175 MEA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 176 MEA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 177 MEA: ULTRASOUND MARKET, BY DISPLAY TYPE, 20192026 (USD MILLION)
TABLE 178 MEA: ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 20192026 (USD MILLION)
TABLE 179 MEA: ULTRASOUND MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 180 MEA: ULTRASOUND MARKET, BY COMPONENT, 20192026 (USD MILLION)
TABLE 181 MEA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 20192026 (USD MILLION)
TABLE 182 MEA: ULTRASOUND MARKET, BY END USER, 20192026 (USD MILLION)
13 COMPETITIVE LANDSCAPE (Page No. - 201)
13.1 OVERVIEW
13.2 KEY PLAYER STRATEGIES
FIGURE 32 KEY DEVELOPMENTS IN THE ULTRASOUND MARKET (2018 TO 2021)
13.3 REVENUE SHARE ANALYSIS
FIGURE 33 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ULTRASOUND MARKET
13.4 MARKET SHARE ANALYSIS: ULTRASOUND MARKET, BY KEY PLAYER (2020)
FIGURE 34 GE HEALTHCARE HELD THE LEADING POSITION IN THE ULTRASOUND MARKET IN 2020
TABLE 183 ULTRASOUND MARKET: DEGREE OF COMPETITION
13.5 COMPANY EVALUATION QUADRANT FOR 25 KEY PLAYERS (2020)
13.5.1 TERMINOLOGY/NOMENCLATURE
13.5.1.1 Stars
13.5.1.2 Emerging leaders
13.5.1.3 Pervasive players
13.5.1.4 Participants
FIGURE 35 ULTRASOUND MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
13.6 COMPANY EVALUATION QUADRANT FOR START-UP/SMES (2020)
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
FIGURE 36 ULTRASOUND MARKET: COMPETITIVE LEADERSHIP MAPPING (SME/START-UPS)
13.7 COMPETITIVE BENCHMARKING
TABLE 184 APPLICATION FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ULTRASOUND MARKET
13.8 COMPETITIVE SCENARIO (20182021)
13.8.1 NEW PRODUCT LAUNCHES AND APPROVALS
TABLE 185 ULTRASOUND MARKET: NEW PRODUCT LAUNCHES AND APPROVALS, 20182021
13.8.2 DEALS
TABLE 186 ULTRASOUND MARKET: DEALS, 20182021
13.8.3 EXPANSIONS
TABLE 187 ULTRASOUND MARKET: EXPANSIONS, 20182021
14 COMPANY PROFILES (Page No. - 213)
14.1 INTRODUCTION
14.2 KEY PLAYERS
(Business overview, Products offered, Recent developments, MNM view)*
14.2.1 GE HEALTHCARE
TABLE 188 GE HEALTHCARE: BUSINESS OVERVIEW
FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT (2020)
14.2.2 KONINKLIJKE PHILIPS N.V.
TABLE 189 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 38 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020)
14.2.3 CANON MEDICAL SYSTEMS CORPORATION
TABLE 190 CANON MEDICAL SYSTEMS CORPORATION: BUSINESS OVERVIEW
FIGURE 39 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2020)
14.2.4 SIEMENS AG
TABLE 191 SIEMENS AG: BUSINESS OVERVIEW
FIGURE 40 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
14.2.5 HITACHI, LTD.
TABLE 192 HITACHI, LTD.: BUSINESS OVERVIEW
FIGURE 41 HITACHI, LTD.: COMPANY SNAPSHOT
14.2.6 HOLOGIC, INC.
TABLE 193 HOLOGIC, INC.: BUSINESS OVERVIEW
FIGURE 42 HOLOGIC, INC.: COMPANY SNAPSHOT
14.2.7 FUJIFILM HOLDINGS CORPORATION
TABLE 194 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
FIGURE 43 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
14.2.8 SAMSUNG ELECTRONICS CO., LTD.
TABLE 195 SAMSUNG ELECTRONICS CO., LTD.: BUSINESS OVERVIEW
FIGURE 44 SAMSUNG ELECTRONICS CO., LTD.: COMPANY SNAPSHOT
14.2.9 MINDRAY MEDICAL INTERNATIONAL LIMITED
TABLE 196 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW
FIGURE 45 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT
14.2.10 ANALOGIC CORPORATION
TABLE 197 ANALOGIC CORPORATION: BUSINESS OVERVIEW
14.2.11 ESAOTE SPA
TABLE 198 ESAOTE S.P.A: BUSINESS OVERVIEW
14.2.12 CARESTREAM HEALTH
TABLE 199 CARESTREAM HEALTH: BUSINESS OVERVIEW
FIGURE 46 ONEX CORPORATION: COMPANY SNAPSHOT
14.2.13 CURA HEALTHCARE
TABLE 200 CURA HEALTHCARE: BUSINESS OVERVIEW
14.2.14 CHISON MEDICAL TECHNOLOGIES CO., LTD.
TABLE 201 CHISON MEDICAL TECHNOLOGIES CO., LTD.: BUSINESS OVERVIEW
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
14.3 OTHER COMPANIES
14.3.1 MOBISANTE, INC.
14.3.2 NEUSOFT CORPORATION
14.3.3 CLARIUS MOBILE HEALTH
14.3.4 MEDGYN PRODUCTS, INC.
14.3.5 UNITED IMAGING HEALTHCARE CO., LTD.
14.3.6 PROMED TECHNOLOGY CO., LTD.
14.3.7 CEPHASONICS
14.3.8 UAB TELEMED
14.3.9 SHENZHEN RICSO TECHNOLOGY CO., LTD.
14.3.10 WUHAN YOUKEY BIO-MEDICAL ELECTRONICS CO., LTD.
15 APPENDIX (Page No. - 268)
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
15.3 AVAILABLE CUSTOMIZATIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the ultrasound market. A database of the key industry leaders was also prepared using secondary research.
Primary research was conducted after acquiring extensive knowledge about the global ultrasound market scenario through secondary research. Primary interviews were conducted with market experts from both the demand-side (such as diagnostic centers, doctors, professors, and hospitals) and supply-side respondents (such as ultrasound device manufacturers and distributors) across five major geographies, namely, North America, Europe, the Asia Pacific, Latin America, and Middle East, and Africa. Approximately 60% of the primary interviews were conducted with stakeholders from the demand side while those from the supply side accounted for the remaining 40%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.
A breakdown of the primary respondents is provided below:
To know about the assumptions considered for the study, download the pdf brochure
A detailed market estimation approach was followed to estimate and validate the size of the global ultrasound market and other dependent submarkets.
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
After deriving the overall ultrasound market value data from the market size estimation process, the total market value data was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all the segments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by studying various qualitative and quantitative variables as well as by analyzing regional trends for both the demand- and supply-side macroindicators.
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the present global ultrasound market report:
Growth opportunities and latent adjacency in Ultrasound Market
Ultrasound is used in many ways according to technology